the health and related economic the health and related
play

The Health and Related Economic The Health and Related Economic - PowerPoint PPT Presentation

The Health and Related Economic The Health and Related Economic Benefits of Attaining Benefits of Attaining Healthful Air in the Healthful Air in the San Joaquin Valley San Joaquin Valley Jane Vise Hall and Victor Brajer Jane Vise Hall and


  1. The Health and Related Economic The Health and Related Economic Benefits of Attaining Benefits of Attaining Healthful Air in the Healthful Air in the San Joaquin Valley San Joaquin Valley Jane Vise Hall and Victor Brajer Jane Vise Hall and Victor Brajer The Institute for Economic and Environmental Studies The Institute for Economic and Environmental Studies California State University, Fullerton California State University, Fullerton Frederick W. Lurmann Frederick W. Lurmann Sonoma Technology, Inc. Sonoma Technology, Inc. 2006 San Joaquin Valley Air Quality Symposium 2006 San Joaquin Valley Air Quality Symposium December 6, Bakersfield, California December 6, Bakersfield, California

  2. Study Objectives Study Objectives • Determine who is exposed to poor air Determine who is exposed to poor air • quality and how frequently. quality and how frequently. • Quantify known adverse health effects Quantify known adverse health effects • that result from exposure. that result from exposure. • Assess the economic value of meeting Assess the economic value of meeting • health- -based air quality standards. based air quality standards. health 2

  3. Research Approach Research Approach • Closely integrated multidisciplinary Closely integrated multidisciplinary • research. research. • Three essential elements: Three essential elements: • – Exposure – Exposure – – Health Health – Economics – Economics 3

  4. Research Approach Schematic Research Approach Schematic Response Air Quality Population Economic Data Functions Economic Exposures Symptoms Valuation (SYMVAL) (REHEX) (SYMVAL) 4

  5. Exposure Exposure • Integrates air quality, spatial and • Integrates air quality, spatial and demographic data. demographic data. • Represents who is exposed as well as • Represents who is exposed as well as frequency of exposure. frequency of exposure. • Supports estimation of adverse health Supports estimation of adverse health • effects associated with exposure. effects associated with exposure. 5

  6. Adverse Health Effects Adverse Health Effects Include effects that: Include effects that: • Are well established in the health literature. • Are well established in the health literature. • Are associated with ozone or PM 2.5 . • Are associated with ozone or PM 2.5 . • Can be quantified in economic terms. • Can be quantified in economic terms. 6

  7. Economics Economics • Attaches dollar values to adverse health Attaches dollar values to adverse health • effects resulting from exposure. effects resulting from exposure. • Provides an easily understood measure Provides an easily understood measure • of the cost of poor air quality. of the cost of poor air quality. • Is not the entire picture: equity. Is not the entire picture: equity. • 7

  8. Health Endpoints Health Endpoints Ozone- -related: related: Ozone • Respiratory Respiratory- -related hospital admissions. related hospital admissions. • • Emergency room visits. Emergency room visits. • • School absences. School absences. • • Asthma attacks. Asthma attacks. • • Days of restricted activity. Days of restricted activity. • 8

  9. Health Endpoints Health Endpoints PM 2.5 -related: related: PM 2.5 - • Premature death (mortality). • Premature death (mortality). • Acute bronchitis, children. • Acute bronchitis, children. • Chronic bronchitis, adults. • Chronic bronchitis, adults. • Work loss days. • Work loss days. • Days of restricted activity. • Days of restricted activity. • Upper and lower respiratory symptoms, children. • Upper and lower respiratory symptoms, children. • Non- -fatal heart attacks. fatal heart attacks. • Non • Respiratory and cardio hospital admissions. • Respiratory and cardio hospital admissions. • Children’s asthma ER- -related visits. related visits. • Children’s asthma ER 9

  10. Other Health Endpoints Other Health Endpoints • Ozone • Ozone- -related mortality. related mortality. • Neonatal PM Neonatal PM- -related mortality. related mortality. • • Loss of lung function. • Loss of lung function. • Asthma hospital admissions. Asthma hospital admissions. • • Adult asthma ER visits. • Adult asthma ER visits. 10

  11. Scope of the Results Scope of the Results • Expected reduction in exposure by attaining • Expected reduction in exposure by attaining the federal (and state) air quality standards. the federal (and state) air quality standards. • Expected improvements in health. Expected improvements in health. • • Economic value gained from fewer adverse Economic value gained from fewer adverse • health effects. health effects. 11

  12. Health Studies Criteria Health Studies Criteria • Are peer Are peer- -reviewed. reviewed. • • Account for potential confounders. • Account for potential confounders. • Are based on similar populations. Are based on similar populations. • • Are more recent, using more advanced • Are more recent, using more advanced analytical methods. analytical methods. • Cover longer periods and larger Cover longer periods and larger • populations. populations. • Have been used in previous peer Have been used in previous peer- - • reviewed benefits assessments. reviewed benefits assessments. 12

  13. Concentration- -Response Equation Response Equation Concentration ? C = -C o (e -ß?P – 1) where: ?C = the change in the number of cases C o = the number of baseline cases ?P = the change in ambient pollution concentrations ß = an exponential “slope” factor derived from the health literature and ß = (1 + Increased Odds)/(? Pollution) 13

  14. PM Mortality Studies Used PM Mortality Studies Used Pope et al. (2002) Pope et al. (2002) • Large scale, longitudinal cohort study. • Large scale, longitudinal cohort study. • 16- -year follow up from 1979 year follow up from 1979- -1983. 1983. • 16 • 61 U.S. cities, ages 30 and older. • 61 U.S. cities, ages 30 and older. • • Controls for lifestyle and occupation. Controls for lifestyle and occupation. • Increase in all- -cause mortality: cause mortality: 6% per 10 ug/m 6% per 10 ug/m 3 . • Increase in all . Jerret et al. (2005) Jerret et al. (2005) • Based on LA subset of Pope study. • Based on LA subset of Pope study. • • Controls for same confounders. Controls for same confounders. • Better represents LA population. • Better represents LA population. • • Finds greater association between traffic Finds greater association between traffic • and health effects. • and health effects. • Increase in all- -cause mortality: cause mortality: 17% per 10 ug/m • Increase in all 17% per 10 ug/m 3 . . 14

  15. Economic Values Economic Values New case of chronic bronchitis New case of chronic bronchitis $374,000 $374,000 Hospitalization $ 32,000 Hospitalization $ 32,000 MRAD $ 61 MRAD $ 61 Work loss day Work loss day $123- $123 -141 141 School absence $ 65- -79 79 School absence $ 65 Respiratory symptom day $ 20- -32 32 Respiratory symptom day $ 20 Acute bronchitis Acute bronchitis $ 110 $ 110 Asthma attack $ 50 Asthma attack $ 50 Emergency room visit $ 325 Emergency room visit $ 325 15

  16. Value of a Statistical Life Value of a Statistical Life One VSL One VSL = = $6,700,000 $6,700,000 Consider this example: Consider this example: • 1,000,000 people are at risk. 1,000,000 people are at risk. • • Risk is reduced for each by 1/100,000 a year. Risk is reduced for each by 1/100,000 a year. • • Each values that reduction at $670, which Each values that reduction at $670, which • totals $670,000,000. totals $670,000,000. • Ten lives are saved: valued at $6,700,000 Ten lives are saved: valued at $6,700,000 • each. each. 16

  17. NAAQS Results – – Annually Annually NAAQS Results 2004 Population 2004 Population • • 460 fewer premature deaths. 460 fewer premature deaths. • 325 fewer new cases of chronic bronchitis. • 325 fewer new cases of chronic bronchitis. • 334,000 fewer days of reduced activity in adults. • 334,000 fewer days of reduced activity in adults. • 345 fewer hospital admissions. • 345 fewer hospital admissions. • 23,300 fewer asthma attacks. • 23,300 fewer asthma attacks. • • 188,000 fewer days of school absence. 188,000 fewer days of school absence. • 3,230 fewer cases of acute bronchitis in children. • 3,230 fewer cases of acute bronchitis in children. • 68,680 fewer work loss days. • 68,680 fewer work loss days. • 595 fewer non- -fatal heart attacks fatal heart attacks • 595 fewer non • 445 fewer children’s asthma ER visits • 445 fewer children’s asthma ER visits • • Over 382,000 Over 382,000 fewer days of respiratory symptoms in children. fewer days of respiratory symptoms in children. 17

  18. Total Value Total Value • $3.3 billion $3.3 billion per year • per year • $1,000 per Valley resident per year $1,000 per Valley resident per year • • Attaining California AQ standards would Attaining California AQ standards would • double the benefits double the benefits 18

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend